«Fascioliasis

Below is an extended Fascioliasis patents listing. Click here to return to the Fascioliasis main in depth entry.

Patents :
US Patent No.	Title
7071196	Chemical compounds
7196164	Secreted protein HHTLF25
7214680	2-substituted 1-arylpiperazines as tachykinin antagonists and/or serotonin reuptake inhibitors
7214692	Medical use for tachykinin antagonists
7217731	Hydroisoindoline tachykinin receptor antagonists
7232667	Keratinocyte growth factor-2 polynucleotides
7238660	Albumin fusion proteins
7238667	Albumin fusion proteins
7250433	Tetrazole and oxadiazolone substituted .beta.-amino acid derivatives
7253284	Chemical compounds
7262859	Systems and methods for measurement optimization
7196113	Lactam tachykinin receptor antagonists
7196077	Tachykinin antagonists
7091315	Protein HDPBQ71
7119083	.beta.-Lactamyl vasopressin V.sub.1a Antagonists
7119092	Chemical compounds
7119207	Benzoamide piperidine containing compounds and related compounds
7141547	Albumin fusion proteins comprising GLP-1 polypeptides
7163797	50 human secreted proteins
7166598	Piperazine derivatives
7179804	Tachykinin receptor antagonists
7189690	Albumin fusion proteins
7189713	Piperidine derivatives
7268125	.beta.-lactamyl vasopressin V.sub.1a antagonists
7273871	Phenyl-5,6,6A,7,8,9-hexahydro-4H-1,4,9-triaza-phenalene derivatives as CRF antagonists
7276509	Piperidine derivatives and their use as antagonists of tachykinins
7368527	HADDE71 polypeptides
7368531	Human secreted proteins
7381800	Antibodies to HBIMF63 polypeptide
7381826	Crystalline forms of {2-[1-(3,5-bis-trifluoromethyl-benzyl)-5-pyridin-4-yl-1H-[1,2,3]triazol-4- -yl]-pyridin-3-yl}-(2-chlorophenyl)-methanone
7405212	Helix mimetics and composition and methods related thereto
7407952	Reverse-turn mimetics and compositions and methods related thereto
7407959	Cathepsin cysteine protease inhibitors
7410970	Substituted 1,4,-di-piperidin-4-yl-piperazine derivatives and their use as neurokinin antagonists
7411051	Antibodies to HDPPA04 polypeptide
7427630	Condensed N-heterocyclic compounds and their use as CRF receptor antagonists
7368432	Conotoxin peptides
7358278	Cellular phosphorylation potential enhancing compositions preparation and use thereof
7279474	Substituted pyrrolo[2,3-d]pyrimidines as antagonists of the corticotropin releasing factor (CRF)
7294630	Piperazinyl piperidine tachykinin antagonists
7312353	Cathespin cysteine protease inhibitors
7320994	Triazole derivatives as tachykinin receptor antagonists
7329667	CRF receptor antagonists
7342028	Medical use for tachykinin antagonists
7345040	Reverse-turn mimetics and compositions and methods relating thereto
7345041	Chemical compounds
7345083	Hydroisoindoline tachykinin receptor antagonists
7351861	Method and probe for identifying bacterial virulence modifying agents, agents thus identified, and their use
7432046	Methods for the determination of antibody IgG avidity

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.